20/20 Biolabs Inc. (AIDX) vs Holdco Nuvo Group D.G Ltd. (NUVOQ)
- 20/20 Biolabs Inc. AIDX 0.20 +5.26%
- Holdco Nuvo Group D.G Ltd. NUVOQ 0.00 NaN
20/20 Biolabs Inc. and Holdco Nuvo Group D.G Ltd. are both Medical Devices companies. 20/20 Biolabs Inc. is the larger, with a market value of $2.5M against $2.1M — 1.2× the size. Holdco Nuvo Group D.G Ltd. has the higher net margin (0.00% vs −298.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Holdco Nuvo Group D.G Ltd. leads on 8 and 20/20 Biolabs Inc. on 3.
Valuation
Profitability
| Metric | AIDX | NUVOQ | Medical Devices median |
|---|---|---|---|
| Gross margin | 32.06% | — | 57.76% |
| Operating margin | (198.15%) | 0.00% | (14.84%) |
| Net margin | (298.16%) | 0.00% | (14.45%) |
| Free cash flow margin | (200.12%) | 0.00% | (5.70%) |
| Return on equity | 0.00% | 63.38% | (10.56%) |
| Return on assets | (211.61%) | (930.47%) | (17.26%) |
| Return on invested capital | 0.00% | 0.00% | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack